Cadamba Solutions Private Limited, a member of the promoter group, has acquired 1,000,000 equity shares of Neogen Chemicals Limited. The allotment, which occurred on April 18, 2026, was executed on a preferential basis at a price of Rs. 1,610 per share. This strategic investment totals Rs. 161 crore, effectively increasing the promoter group’s stake and providing fresh capital to support the company’s growth objectives.
Details of the Preferential Allotment
Neogen Chemicals Limited successfully concluded the issuance of 1,000,000 equity shares through a preferential allotment. The shares were issued at a face value of Rs. 10, with a substantial premium of Rs. 1,600 per share, bringing the total issue price to Rs. 1,610 per share. The transaction, valued at Rs. 161,00,00,000, reflects strong confidence from the promoter group in the company’s long-term value creation.
Impact on Shareholding Structure
Following this allotment, the total paid-up equity capital of Neogen Chemicals Limited has increased from Rs. 26,38,16,740 (comprising 2,63,81,674 shares) to Rs. 27,38,16,740 (comprising 2,73,81,674 shares). This acquisition represents a 3.79% stake of the pre-allotment capital and 3.65% of the post-allotment paid-up equity capital. The acquired securities carry standard voting rights, further consolidating the promoter’s influence within the target company.
Transaction Rationale
The acquisition was finalized on April 18, 2026, as part of the company’s broader efforts to strengthen its capital base. By securing these shares, the acquirer, Cadamba Solutions Private Limited, has bolstered its position within the promoter group, ensuring continued commitment to the organizational goals and future expansion plans of Neogen Chemicals Limited.
Source: BSE
